Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic Alopecia
Alopecia, Androgenetic
About this trial
This is an interventional treatment trial for Alopecia, Androgenetic focused on measuring Androgenetic Alopecia, Centrifugation, Platelet-rich plasma, Thrombocyte
Eligibility Criteria
Inclusion Criteria: Met the criteria of androgenic alopecia (Hamilton Norwood grade III-IV) Men between ages 25-59 years old Have stopped taking topical anti-androgen or minoxidil for at least one month, or oral anti-androgen or minoxidil for at least three months Exclusion Criteria: alopecia of any other type subject with a history of keloid or blood coagulation disorders underwent anticoagulant therapy subjects on Non-Steroidal Anti-Inflammatory Drugs (NSAID) medications in seven days prior to the study subjects who had hair treatment using growth factors, including PRP and microneedling within at least six months prior to the study.
Sites / Locations
- Cipto Mangunkusumo General HospitalRecruiting
- Universitas Indonesia
Arms of the Study
Arm 1
Arm 2
Other
Active Comparator
Single Spin Group
Double Spin Group
Currently, the standard operating procedures for PRP preparation in dr. Cipto Mangunkusumo National General Hospital is by performing a single-spin centrifugation at 3000 rpm for 15 minutes. This first group will received PRP treatment by single-spin centrifugation at 3000 rpm in 15 minutes in addition to topical minoxidil (5%)
This group will received double-spin centrifugation PRP treatment at 1500 rpm in 6 minutes and continued at 2500 rpm in 15 minutes in addition to topical minoxidil (5%)